Pathway id | Description | Ratio_in_study | Ratio_in_pop | Percent | P value |
---|---|---|---|---|---|
Map00830 | Retinol metabolism | 23/665 | 143/22793 | 16.08% | 1.4977E-08 |
Map00140 | Steroid hormone biosynthesis | 22/665 | 144/22793 | 15.28% | 2.6183E-08 |
Map05204 | Chemical carcinogenesis | 23/665 | 176/22793 | 13.07% | 1.3555E-07 |
Map00590 | Arachidonic acid metabolism | 19/665 | 127/22793 | 14.96% | 2.8598E-07 |
Map04062 | Chemokine signaling pathway | 24/665 | 241/22793 | 9.96% | 8.3868E-06 |
Map00980 | Metabolism of xenobiotics by cytochrome P450 | 15/665 | 137/22793 | 10.95% | 0.00035448 |
Map04750 | Inflammatory mediator regulation of TRP channels | 16/665 | 161/22793 | 9.94% | 0.00056316 |
Map00100 | Steroid biosynthesis | 6/665 | 23/22793 | 26.09% | 0.00098829 |
Map00591 | Linoleic acid metabolism | 10/665 | 72/22793 | 13.89% | 0.00099817 |
Map00062 | Fatty acid elongation | 7/665 | 38/22793 | 18.42% | 0.00210167 |
Map00982 | Drug metabolism-cytochrome P450 | 12/665 | 119/22793 | 10.08% | 0.00324254 |
Map04152 | AMPK signaling pathway | 14/665 | 160/22793 | 8.75% | 0.00416512 |
Map03320 | PPAR signaling pathway | 12/665 | 127/22793 | 9.45% | 0.00529036 |
Map00071 | Fatty acid degradation | 8/665 | 63/22793 | 12.70% | 0.00646651 |
Map04923 | Regulation of lipolysis in adipocytes | 8/665 | 66/22793 | 12.12% | 0.00846127 |
Map04145 | Phagosome | 27/665 | 474/22793 | 5.70% | 0.00990327 |
Map01040 | Biosynthesis of unsaturated fatty acids | 6/665 | 39/22793 | 15.38% | 0.01027708 |
Map00520 | Amino sugar and nucleotide sugar metabolism | 8/665 | 70/22793 | 11.43% | 0.01099148 |
Map04512 | ECM-receptor interaction | 9/665 | 88/22793 | 10.23% | 0.01163767 |
Map04650 | Natural killer cell mediated cytotoxicity | 19/665 | 302/22793 | 6.29% | 0.01575303 |
Map04974 | Protein digestion and absorption | 9/665 | 97/22793 | 9.28% | 0.01992439 |
Map04060 | Cytokine-cytokine receptor interaction | 19/665 | 311/22793 | 6.11% | 0.02042395 |
Map04918 | Thyroid hormone synthesis | 8/665 | 82/22793 | 9.76% | 0.02369879 |
Map04931 | Insulin resistance | 10/665 | 121/22793 | 8.26% | 0.02475499 |
Map04930 | Type II diabetes mellitus | 7/665 | 69/22793 | 10.14% | 0.03251649 |
Map04920 | Adipocytokine signaling pathway | 7/665 | 72/22793 | 9.72% | 0.0399927 |
Map04620 | Toll-like receptor signaling pathway | 9/665 | 111/22793 | 8.11% | 0.04083019 |
Map04080 | Neuroactive ligand-receptor interaction | 19/665 | 341/22793 | 5.57% | 0.04192223 |
Map04666 | Fc gamma R-mediated phagocytosis | 15/665 | 244/22793 | 6.15% | 0.0422101 |
Map00900 | Terpenoid backbone biosynthesis | 5/665 | 40/22793 | 12.50% | 0.04231822 |
Map04012 | Erbb signaling pathway | 9/665 | 115/22793 | 7.83% | 0.04606007 |